Related references
Note: Only part of the references are listed.Exploring the Clinical Utility of Pancreatic Cancer Circulating Tumor Cells
Dannel Yeo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Prognostic Implications of Portal Venous Circulating Tumor Cells in Resectable Pancreatic Cancer
Young Hoon Choi et al.
BIOMEDICINES (2022)
Circulating tumor cells detected in follow-up predict survival outcomes in tri-modality management of advanced non-metastatic esophageal cancer: a secondary analysis of the QUINTETT randomized trial
Edward Yu et al.
BMC CANCER (2022)
PD-L1 expression on circulating tumor cells can be a predictive biomarker to PD-1 inhibitors combined with radiotherapy and antiangiogenic therapy in advanced hepatocellular carcinoma
Ke Su et al.
FRONTIERS IN ONCOLOGY (2022)
Neoadjuvant therapy in resectable pancreatic cancer: A promising curative method to improve prognosis
Hao-Qi Zhang et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2022)
The Value of Circulating Tumor Cells in the Prognosis and Treatment of Pancreatic Cancer
Kai Luo et al.
FRONTIERS IN ONCOLOGY (2022)
Measurement of Portal Vein Blood Circulating Tumor Cells is Safe and May Correlate With Outcomes in Resected Pancreatic Ductal Adenocarcinoma
Michael G. White et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
Liquid biopsy enters the clinic - implementation issues and future challenges
Michail Ignatiadis et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Circulating tumour cells in pancreatic cancer: A systematic review and meta-analysis of clinicopathological implications
Tony C. Y. Pang et al.
PANCREATOLOGY (2021)
Detection of Circulating Tumor Cells in Resectable Pancreatic Ductal Adenocarcinoma: A Prospective Evaluation as a Prognostic Marker
Byeong Geun Song et al.
FRONTIERS IN ONCOLOGY (2021)
Characterisation of circulating tumour cell phenotypes identifies a partial-EMT sub-population for clinical stratification of pancreatic cancer
Alexander Semaan et al.
BRITISH JOURNAL OF CANCER (2021)
Endoscopic Ultrasound-Guided Acquisition of Portal Venous Circulating Tumor Cells as a Potential Diagnostic and Prognostic Tool for Pancreatic Cancer
Yixuan Zhang et al.
CANCER MANAGEMENT AND RESEARCH (2021)
Circulating Tumor Cells Enumeration from the Portal Vein for Risk Stratification in Early Pancreatic Cancer Patients
Javier Padillo-Ruiz et al.
CANCERS (2021)
Portal Venous Circulating Tumor Cells Undergoing Epithelial-Mesenchymal Transition Exhibit Distinct Clinical Significance in Pancreatic Ductal Adenocarcinoma
Yujin Pan et al.
FRONTIERS IN ONCOLOGY (2021)
Liquid Biopsy: From Discovery to Clinical Application
Catherine Alix-Panabieres et al.
CANCER DISCOVERY (2021)
Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review
Jinshou Yang et al.
CANCER COMMUNICATIONS (2021)
Circulating tumor cells in peripheral blood of pancreatic cancer patients and their prognostic role: a systematic review and meta-analysis
Yang Wang et al.
HPB (2020)
HER2-targeted therapy influences CTC status in metastatic breast cancer
Thomas M. Deutsch et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Annual report to the nation on the status of cancer, part I: National cancer statistics
S. Jane Henley et al.
CANCER (2020)
AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review
Harry R. Aslanian et al.
GASTROENTEROLOGY (2020)
Endoscopic ultrasound acquired portal venous circulating tumor cells predict progression free survival and overall survival in patients with pancreaticobiliary cancers
Christopher G. Chapman et al.
PANCREATOLOGY (2020)
Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma
Vincent P. Groot et al.
ANNALS OF SURGERY (2019)
Stromal biology and therapy in pancreatic cancer: ready for clinical translation?
Albrecht Neesse et al.
GUT (2019)
Circulating Tumor Cells in Pancreatic Cancer: Current Perspectives
Verena Martini et al.
CANCERS (2019)
Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice
Xiao-Hui Zhao et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Circulating tumor cells in lung cancer are prognostic and predictive for worse tumor response in both targeted- and chemotherapy
Menno Tamminga et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2019)
The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer
Xiuwen Guan et al.
CANCER COMMUNICATIONS (2019)
Circulating tumor DNA and liquid biopsy: opportunities, challenges, and recent advances in detection technologies
Lena Gorgannezhad et al.
LAB ON A CHIP (2018)
Detection of CTCs in portal vein was associated with intrahepatic metastases and prognosis in patients with advanced pancreatic cancer
Xiaoyu Liu et al.
JOURNAL OF CANCER (2018)
Identification of the tumour transition states occurring during EMT
Ievgenia Pastushenko et al.
NATURE (2018)
Fractional uptake of circulating tumor cells into liver-lung compartments during curative resection of periampullary cancer
Caroline Vilhav et al.
ONCOLOGY LETTERS (2018)
Circulating Tumor and Invasive Cell Gene Expression Profile Predicts Treatment Response and Survival in Pancreatic Adenocarcinoma
Kenneth H. Yu et al.
CANCERS (2018)
Circulating Tumor Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular Carcinoma
Yun-Fan Sun et al.
CLINICAL CANCER RESEARCH (2018)
Circulating Tumor Cells Expressing Markers of Tumor-Initiating Cells Predict Poor Survival and Cancer Recurrence in Patients with Pancreatic Ductal Adenocarcinoma
Katherine E. Poruk et al.
CLINICAL CANCER RESEARCH (2017)
EUS-guided portal vein interventions
Guru Trikudanathan et al.
GASTROINTESTINAL ENDOSCOPY (2017)
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
Joshua D. Cohen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations
Birte Kulemann et al.
SCIENTIFIC REPORTS (2017)
Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma
Katherine E. Poruk et al.
ANNALS OF SURGERY (2016)
Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer
J. S. Ankeny et al.
BRITISH JOURNAL OF CANCER (2016)
A High Circulating Tumor Cell Count in Portal Vein Predicts Liver Metastasis From Periampullary or Pancreatic Cancer A High Portal Venous CTC Count Predicts Liver Metastases
Yu Wen Tien et al.
MEDICINE (2016)
Metastatic colonization by circulating tumour cells
Joan Massague et al.
NATURE (2016)
Genomic analyses identify molecular subtypes of pancreatic cancer
Peter Bailey et al.
NATURE (2016)
Acquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic Ultrasound
Daniel V. T. Catenacci et al.
GASTROENTEROLOGY (2015)
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
Kari R. Fischer et al.
NATURE (2015)
Portal vein-circulating tumor cells predict liver metastases in patients with resectable pancreatic cancer
Massimiliano Bissolati et al.
TUMOR BIOLOGY (2015)
Liquid Biopsies: Genotyping Circulating Tumor DNA
Luis A. Diaz et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Success and failure rates of tumor genotyping techniques in routine pathological samples with non-small-cell lung cancer
Paul A. VanderLaan et al.
LUNG CANCER (2014)
Single-Cell RNA Sequencing Identifies Extracellular Matrix Gene Expression by Pancreatic Circulating Tumor Cells
David T. Ting et al.
CELL REPORTS (2014)
Circulating Tumor Cells and Prognosis of Patients with Resectable Colorectal Liver Metastases or Widespread Metastatic Colorectal Cancer: A Meta-Analysis
Bas Groot Koerkamp et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Microfluidics and Circulating Tumor Cells
Yi Dong et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2013)
Circulating tumor cells in prostate cancer: A potential surrogate marker of survival
Jerome Doyen et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2012)
Considerations in the development of circulating tumor cell technology for clinical use
David R. Parkinson et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients
Robert Koenigsberg et al.
ACTA ONCOLOGICA (2011)
Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non-Small-Cell Lung Cancer
Matthew G. Krebs et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Metastatic colorectal cancer KRAS genotyping in routine practice: results and pitfalls
Aude Lamy et al.
MODERN PATHOLOGY (2011)
The patterns and dynamics of genomic instability in metastatic pancreatic cancer
Peter J. Campbell et al.
NATURE (2010)
Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients withMetastaticBreast Colorectal and Prostate Cancer
M. Craig Miller et al.
JOURNAL OF ONCOLOGY (2010)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Share Paper
